# Final readiness report (supervisor package)

**Date:** 2026-09-10  
**Package root:** `results/final_submission_package/`  
**Frozen scientific draft:** `manuscript/manuscript_supervisor_v1.md` (also mirrored as `results/phase14_submission_prep/manuscript/manuscript_genome_biology_supervisor_v1.md`)

---

## A. Final recommended title
**Reliability of deep generative single-cell multi-omics models under distribution shift and uncertainty-guided prediction**

## B. Current manuscript word count
**≈2,840 words** (full markdown file, including legends/declarations/references).  
Main narrative sections approximately: Background 182 · Results 707 · Discussion 272 · Conclusions 58 · Methods 524.

## C. Abstract word count
**≈212 words** (Background/Results/Conclusions body; keywords excluded).

## D. Main figures complete?
**Yes** — Figures 1–6 as PDF+PNG under `figures/`. Human visual QC at single-/double-column still required (`logs/final_figure_qc.md`).

## E. Supplement plan complete?
**Yes** — `supplement/supplementary_plan.md` (S1–S14 + ST1–ST9 plan). Actual supplementary figure assembly files not re-exported in this packaging step.

## F. References complete?
**Mostly** — 12 numbered refs with DOIs/URLs in `references/references_final.md`. NeurIPS page ranges and truncated “et al.” lists remain polish items.

## G. Unresolved references
See `references/unresolved_references.md`: NeurIPS (7, 11) page-range format; expand Lotfollahi/Hao author lists if required; Lawlor author list **completed** from Frontiers page.

## H. PHASE 10 contamination found?
**No** — `logs/final_phase10_integrity_check.md`.

## I. PHASE 12A interpretation correct?
**Yes** — residual/run-level stochastic variability dominates; manuscript does **not** say “interaction dominates.”

## J. Missing-modality wording correct?
**Yes** — PHASE 8 = entry-wise corruption; missing modality only as limitation / non-experiment.

## K. Lawlor independence wording correct?
**Yes** — author labels; Hao/Seurat-v4 for development only; GSE164378 not used as Lawlor accession.

## L. All numerical headline claims verified?
**Yes against frozen package tables/prior ledger** (Lawlor F1 0.800/0.888/Δ+0.088; pred AUROC 0.801/0.838; latent 0.605/0.650; AURC 0.087/0.036; internal pred ≈0.84–0.86; latent ranges as stated). No invented p-values.

## M. All literature claims cited?
**Yes for method/prior-art statements in the draft** (CITE-seq, scVI, totalVI, MOFA+, scArches, integration benchmarks, calibration/selective prediction, MultiVI/PoE context). Novelty-audit extras optional.

## N. Number of manual placeholders remaining
**≥8 human-input fields:** authors/order/affiliations/corresponding author; funding; acknowledgements; CRediT contributions; competing-interests confirm; ethics confirm if needed; Zenodo DOI; public code-release approval. Cover letter also has author contact placeholders.

## O. Remaining human inputs required
Author metadata; funding; acknowledgements; contributions; journal-guideline live confirm; figure visual QC; public data/code release; cover-letter signatures; supervisor answers to review questions.

## P. Strongest paper contribution
Disciplined **reliability characterization** of deep generative multi-omics models under shift/stochasticity/uncertainty-guided prediction, with independent donor-held-out replication—**without** claiming a new architecture.

## Q. Strongest quantitative result
Lawlor macro-F1 **0.800 → 0.888** (Δ **+0.088**; **50/50** paired runs favor totalVI).

## R. Strongest uncertainty result
Predictive error AUROC strong internally (≈0.84–0.86) and externally (0.801 vs 0.838); latent AUROC model-dependent (internal totalVI ≈0.61–0.67 vs scVI ≈0.47–0.54; Lawlor 0.650 vs 0.605); Lawlor AURC **0.036** vs **0.087**.

## S. Strongest negative finding
Multimodal transfer benefit is **not universal** (Direction A near null under 20-seed interpretation) and abstention creates **severe cell-type retention imbalance**.

## T. Strongest limitation
PBMC-only cohorts; partial Lawlor labels; 12-protein overlap; no stimulation-shift / 39-ADT / external source-composition in primary package; no honest cell-wise missing-modality experiment under totalVI 1.3.3.

## U. Number of reviewer concerns requiring a new experiment
**0 currently required.** Up to **3 optional contingencies** documented (stim / 39-ADT / external source-comp).

## V. Whether stimulation is currently REQUIRED
**No.**

## W. Whether manuscript is ready to send to supervisor
**Yes** — for scientific review of the frozen package.

## X. Whether manuscript is ready to submit without supervisor/human review
**No.**

## Y. Exact remaining steps before submission
1. Supervisor scientific review + answers to review questions.  
2. Fill author/funding/acknowledgements/contributions/competing interests.  
3. Human figure/table visual QC.  
4. Live Genome Biology guideline confirmation on Springer/BMC.  
5. Bibliographic polish (NeurIPS format; expand et al. if required).  
6. Assemble publisher-ready supplementary files from plan.  
7. Approve and execute public code + data archival (Zenodo DOI when real).  
8. Finalize cover letter.  
9. Upload only after explicit human approval — **do not submit from this package build.**

---

## STOP
No experiments run. Frozen results unchanged. No commit/push/Zenodo/publicize/submit.
